The Clorox Company (CLX)
Free
No email, no account, no signup.
Pulling latest news for The Clorox Company…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report –
Order analysis – $4.99 $1.25
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NYSE
Type
Producer
Sector
Consumer goods and cleaning products
Market Cap
$10.4B
Market sentiment
Sentiment has weakened as leadership uncertainty and ongoing margin/guidance concerns dominate, partially offset by product innovation and secured financing.
Why NEUTRAL ?
The CEO transition introduces hard-to-model strategic and execution uncertainty while leverage increases via the new debt issuance; the setup warrants a review ahead of the Q4 print and further updates on the CEO search, despite potentially positive longer-term Healthcare innovation.
- Wait/review: hold only if you can tolerate higher leadership and execution risk; defer new buying until there is clearer CEO visibility and Q4 guidance.
We're already tracking The Clorox Company — here are the latest events we've registered
Recent News
- Since the last analysis, Clorox priced a total $1.5B senior notes offering (maturities 2031/2033/2036) for refinancing and general corporate purposes. On May 28–29, CEO and Chair Linda Rendle announced she plans to step down for health reasons; the board initiated a comprehensive CEO search and Rendle will remain until a successor is appointed (then serve as an advisor). In early June, Clorox Healthcare introduced new disinfecting wipes (including HyperOxi sporicidal and Quat Alcohol) that could strengthen its infection-prevention portfolio. The stock sold off on the CEO news and partially rebounded afterward.
Want to know how this news affects The Clorox Company? Order the analysis.
Order analysis – Catalysts
30 Jul 2026 — Q4 FY2026 earnings
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Sources: news, filings, market data, and investor forums
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of The Clorox Company will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.